Form 4 for URGN UroGen Pharma Ltd.
Accepted 2026-02-04 00:00:00 ET · period of report 2026-02-03 · accession 0001437749-26-003040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-04 | 2026-02-03 | URGN | Schoenberg Mark | Chief Medical Off | S - Sale | $19.69 | -7,373 | 150.5K | -5% | -$145.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-02-03 | S | D | 1,843 | $19.69 | 148,671 | D | — | — | (F1) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| 2 | Common | Ordinary Shares | 2026-02-03 | S | D | 3,686 | $19.69 | 144,985 | D | — | — | (F1) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| 3 | Common | Ordinary Shares | 2026-02-03 | S | D | 1,844 | $19.69 | 150,514 | D | — | — | (F1) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |